What is the treatment for paracetamol (acetaminophen) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Paracetamol (Acetaminophen) Poisoning

Immediately administer N-acetylcysteine (NAC) to all patients with paracetamol levels above the treatment line on the Rumack-Matthew nomogram, or when hepatotoxicity is suspected, as this is the only proven antidote that reduces mortality and prevents liver failure. 1

Initial Management and Decontamination

  • Administer activated charcoal (1 g/kg orally) within 4 hours of ingestion, ideally within 1-2 hours, just prior to starting NAC 1, 2
  • Do not delay NAC administration while waiting for activated charcoal 1
  • Ensure adequate airway protection before giving activated charcoal, especially with co-ingestions 1

Risk Assessment Using the Rumack-Matthew Nomogram

  • Obtain serum paracetamol concentration at least 4 hours post-ingestion (earlier levels are unreliable and may underestimate peak concentrations) 1, 2
  • Plot the concentration on the Rumack-Matthew nomogram to determine treatment need 1, 2
  • The nomogram only applies to single acute ingestions with known timing within 24 hours 1
  • Patients with levels at or above the "possible toxicity" line (150 mg/L at 4 hours in the US; 100 mg/L at 4 hours in the UK) require NAC treatment 1, 3

Critical Caveat About the Nomogram

  • The nomogram underestimates risk in chronic alcoholics, malnourished patients, and those on CYP2E1-inducing drugs (e.g., isoniazid) - treat these patients even with "non-toxic" levels 1, 2
  • Severe hepatotoxicity has been documented with doses as low as 4-5 g/day in chronic alcohol users 4

NAC Dosing Regimen

  • Total dose: 300 mg/kg intravenous over 21 hours, given as three separate infusions 2
  • NAC must be diluted before administration (hyperosmolar at 2600 mOsmol/L) 2
  • Loading dose: 150 mg/kg over 15 minutes to 2 hours (slower infusion reduces adverse reactions) 2, 3
  • Second dose: 50 mg/kg over 4 hours 2
  • Third dose: 100 mg/kg over 16 hours 2

Alternative Two-Bag Regimen

  • Newer protocol: 200 mg/kg over 4 hours, then 100 mg/kg over 16 hours - this has similar efficacy but significantly reduced adverse reactions compared to the three-bag regimen 5

Time-Critical Treatment Windows

  • NAC initiated within 8 hours: 2.9% risk of severe hepatotoxicity 1
  • NAC initiated within 10 hours: 6.1% risk of severe hepatotoxicity 1
  • NAC initiated after 10 hours: 26.4% risk of severe hepatotoxicity 1
  • Treatment remains beneficial even beyond 24 hours, though efficacy is significantly diminished 1, 6

Special Clinical Scenarios Requiring Immediate NAC

Unknown Time of Ingestion

  • Administer NAC loading dose immediately without waiting for laboratory results 1, 2
  • Obtain paracetamol concentration to guide continuation of treatment 2

Presentation >8 Hours Post-Ingestion

  • Start NAC immediately before obtaining paracetamol levels 1, 2
  • Do not wait for nomogram interpretation 1

Acetaminophen Level Unavailable Within 8 Hours

  • Administer full 21-hour NAC course immediately 2

Fulminant Hepatic Failure

  • Administer NAC regardless of time since ingestion (Level B recommendation) 1
  • NAC reduces mortality from 80% to 52%, cerebral edema from 68% to 40%, and need for inotropic support from 80% to 48% 1
  • Early NAC treatment (<10 hours) in fulminant hepatic failure results in 100% survival 1
  • Late NAC treatment (>10 hours) results in 37% mortality and 51% requiring dialysis 1

Repeated Supratherapeutic Ingestions (RSTI)

  • The Rumack-Matthew nomogram does NOT apply 2
  • Administer NAC if serum paracetamol concentration ≥10 mg/mL OR if AST or ALT >50 IU/L 1
  • Obtain paracetamol concentration and liver function tests to guide treatment 2

Extended-Release Formulations

  • Obtain second paracetamol level 8-10 hours post-ingestion if first level (at 4 hours) is below treatment line 2
  • All potentially toxic ingestions (≥10 g or ≥200 mg/kg) should receive full NAC course 5

Massive Overdoses

  • Ingestions ≥30 g or ≥500 mg/kg require increased doses of NAC 5
  • Paracetamol concentrations more than double the nomogram line warrant increased NAC dosing 5

Monitoring During Treatment

  • Obtain baseline labs: AST, ALT, bilirubin, INR, creatinine, BUN, glucose, and electrolytes 2
  • Monitor for hypersensitivity reactions during NAC infusion 2
  • If severe hypersensitivity occurs, immediately discontinue infusion, treat the reaction, then carefully restart NAC 2

Disposition Based on Severity

  • Patients with AST >1000 IU/L or coagulopathy require ICU-level care and early transplant hepatology consultation 1
  • Liver damage (defined as ALT >1000 U/L) is associated with presentation >15 hours after ingestion 6

Common Pitfalls to Avoid

  • Do not rely on patient-reported ingestion quantity - history is often inaccurate 2
  • Do not use the nomogram for presentations >24 hours post-ingestion - base treatment decisions on paracetamol levels and liver function tests 1
  • Do not withhold NAC in late presenters - it does not worsen outcomes and may still provide benefit 2
  • Do not assume therapeutic doses are safe in high-risk patients - therapeutic doses of 4 g/day for 14 days cause ALT elevation >3× normal in 31-41% of healthy adults 4
  • Reduce total fluid volume in patients <40 kg or those requiring fluid restriction to avoid fluid overload 2

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Paracetamol poisoning--occurrence and treatment].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.